跳至主要内容
临床试验/NCT04488393
NCT04488393已完成不适用

Clinical Performance of NIPT (Noninvasive Prenatal Testing) in Multiple Gestation Pregnancies (SCMM-T21-110)

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,000
试验地点
1
主要终点
Determination of sensitivity of NIPT detection of trisomy 21 among a population of women with twin gestations.

研究概览

简要总结

This study plans to evaluate the clinical performance of the MaterniT21 PLUS and/or GENOME Laboratory Developed Test, in the detection of fetal trisomy 21 in circulating cell-free DNA extracted from maternal blood samples obtained from women pregnant with a twin gestation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • subject pregnant with a multiple gestation and received NIPT from Sequenom Laboratories;
  • subject was 18 or older at the time of NIPT

排除标准

  • 未提供

结局指标

主要结局

Determination of sensitivity of NIPT detection of trisomy 21 among a population of women with twin gestations.

时间窗: time from maternal blood draw to delivery

Determination of specificity of NIPT detection of trisomy 21 among a population of women with twin gestations.

时间窗: time from maternal blood draw to delivery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lorraine Dugoff

Professor of Obstetrics and Gynecology

University of Pennsylvania

研究点 (1)

Loading locations...

相似试验